首页> Blood cancer journal> Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment.

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment.

导出 OA

翻译打印收藏纠错

第一作者： Malin,Hultcrantz

第一单位： Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org.

作者： Malin,Hultcrantz ^[1] ; Even Holth,Rustad ^[2] ; Venkata,Yellapantula ^[2] ; Maria,Arcila ^[3] ; Caleb,Ho ^[3] ; Mustafa H,Syed ^[3] ; Elli,Papaemmanuil ^[4] ; Yanming,Zhang ^[5] ; Francesco,Maura ^[2] ; Ola,Landgren ^[6]

作者单位： Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org. ^[1] Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[2] Hematopathology Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[3] Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[4] Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[5] Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. landgrec@mskcc.org. ^[6]